- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership
Hong Kong Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership
Results
8
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
8 companies
Ascentage Pharma Group International
Market Cap: HK$23.7b
A clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China.
6855
HK$64.50
7D
-1.6%
1Y
57.1%
RemeGen
Market Cap: HK$49.6b
A biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States.
9995
HK$80.60
7D
-8.1%
1Y
355.9%
Akeso
Market Cap: HK$108.4b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.
9926
HK$117.70
7D
3.2%
1Y
74.2%
Ocumension Therapeutics
Market Cap: HK$7.0b
Operates as an ophthalmic pharmaceutical platform company in the People's Republic of China.
1477
HK$8.62
7D
1.3%
1Y
62.9%
InnoCare Pharma
Market Cap: HK$28.2b
A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.
9969
HK$14.58
7D
3.4%
1Y
107.1%
Nanjing Leads Biolabs
Market Cap: HK$11.4b
A clinical-stage biotechnology company, engages in the research, development, and commercialisation of novel antibody drugs worldwide.
9887
HK$57.40
7D
2.0%
1Y
n/a
CanSino Biologics
Market Cap: HK$15.1b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$43.98
7D
-2.3%
1Y
39.0%
JBM (Healthcare)
Market Cap: HK$2.3b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$2.85
7D
-1.0%
1Y
124.4%